期刊文献+

卵巢癌的二元论及其相关蛋白表达差异 被引量:2

Dualism of ovarian cancer and thedifference of protein expression
下载PDF
导出
摘要 目的比较E-钙粘附素(E-Cadherin)、β-连环蛋白(β-catenin)、第10号染色体缺失的磷酸酶和张力蛋白同源物基因(PTEN)、磷脂酰肌醇-3激酶(PI3K)、蛋白激酶B(PKB/Akt)以及P53蛋白,在低级别浆液性癌(LGSC)、高级别浆液性癌(HGSC)、早期透明细胞癌(ECCC)与晚期透明细胞癌(ACCC)中表达的差异,探讨卵巢癌(OC)的二元论发病机制。方法收集我院2002年1月~2017年11月100例OC石蜡包埋组织,应用M.D.Anderson癌症中心的两级组织学分级系统将卵巢浆液性癌(OSC)进行分级,运用国际妇产科联盟(FIGO)分期系统将OC分期,采用免疫组织化学法检测22例LGSC、38例HGSC、20例ECCC以及20例ACCC组织中E-Cadherin、β-Catenin、PTEN、PI3K110α、p-AktSer 473以及P53蛋白表达,并结合临床病理特征进行统计分析。结果E-Cadherin、β-Catenin蛋白表达在LGSC与HGSC以及ECCC与ACCC之间比较差异均有统计学意义(P<0.05)。PTEN、PI3K110α、p-AktSer 473以及P53蛋白表达在LGSC与HGSC以及ECCC与ACCC之间比较差异均有统计学意义(P<0.05)。在LGSC与ECCC中E-Cadherin、β-Catenin蛋白表达均呈负相关(P<0.05),在HGSC中PTEN与PI3Kp110α、p-AktSer473以及P53蛋白表达均呈负相关(P<0.05),在ECCC中PTEN与PI3Kp110α以及p-AktSer473蛋白表达均呈负相关(P<0.05)。发病年龄≤50与>50、G1~2与G3以及Ⅰ~Ⅱ与Ⅲ~Ⅳ期在LGSC与HGSC以及ECCC与ACCC之间比较差异均有统计学意义(P<0.05)。结论E-Cadherin蛋白表达的缺失和β-Catenin蛋白的过度激活共同参与LGSC以及ECCC的发生、发展,而PTEN蛋白表达的缺失,PI3K110α以及p-AktSer 473蛋白的过度激活共同参与HGSC及ECCC的发生、发展,P53蛋白的过度激活参与HGSC及ACCC的发生、发展,这为探讨OC的二元论发病机制、临床诊治以及预后判断提供了依据。 Objective To compare the expression of E-Cadherin,β-Catenin,PTEN,PI3K110α,p-AktSer 473 and P53 proteins in low grade serous carcinoma(LGSC),high grade serous carcinoma(HGSC),early clear cell carcinoma(ECCC)and advanced clear cell carcinoma(ACCC),explore the dualistic mechanism of ovarian cancer(OC)and provide the basis for diagnosis and treatment of prognosis.Methods The ovarian serous carcinoma(OSC)was graded using a two-level histological grade system at M.D.Anderson cancer center.The OC stage was staged using the international union of obstetrics and gynecology(FIGO)staging system.The expression of E-Cadherin,β-Catenin,PTEN,PI3K110α,p-AktSer473 and P53 protein in 22 LGSC,38 HGSC,20 ECCC,and 20 ACCC tissues was examined by immunohistochemical method and statistically analyzed in combination with clinicopathological features.Results The expression of E-Cadherin,β-Catenin protein was statistically significant between LGSC and HGSC between ECCC and ACCC(P<0.05).The expression of PTEN,PI3K110α,p-AktSer 473 and P53 protein was statistically significant between LGSC and HGSC between ECCC and ACCC(Pp<0.05).In LGSC,the expression of E-Cadherin andβ-Catenin protein was negatively correlated(P<0.05).In HGSC,PTEN was negatively correlated with the expression of PI3K110α,p-AktSer 473 and P53 protein(P<0.05),and in ECCC,PTEN was negatively correlated with the expression of PI3K110α,p-AktSer 473(P<0.05).The difference between LGSC and HGSC between ECCC and ACCC between age≤50 and>50 was statistically significant(P<0.05).The difference between LGSC and HGSC between ECCC and ACCC between G1~2 and G3 was statistically significant(P<0.05).The difference between clinical stageⅠ-ⅡandⅢ-Ⅳwas statistically significant between LGSC and HGSC between ECCC and ACCC(P<0.05).Conclusion The deletion of E-Cadherin protein expression and the excessive activation ofβ-Catenin protein may be involved in the occurrence and development of LGSC and ECCC.The deletion of PTEN protein expression and the excessive activation of PI3K110α,and p-AktSer 473 protein may participate in the occurrence and development of HGSC and ECCC.The excessive activation of p53 protein is involved in the development of HGSC and ACCC,which provides a basis for exploring the dualistic pathogenesis,clinical diagnosis and treatment of OC.
作者 陈胜民 王国平 林志仁 袁峰 CHEN Shengmin;WANG Guoping;LIN Zhiren;YUAN Feng(The Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China)
出处 《西部医学》 2020年第11期1599-1603,共5页 Medical Journal of West China
关键词 卵巢癌 上皮型-钙粘蛋白 Β-连环蛋白 PTEN-PI3K/Akt信号通路 P53蛋白 Ovarian carcinoma E-Cadherin β-Catenin PTEN-PI3K/Akt Signal transduction pathway P53 protein
  • 相关文献

参考文献5

二级参考文献73

  • 1陈京来,郎锦义.原发性肝细胞癌的早期诊断[J].西部医学,2006,18(4):491-493. 被引量:3
  • 2SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012 [ J ]. CA Cancer J Clin,2012,62 : 10- 29.
  • 3SEROV S F, SCULLY R E, SOBIN L H. Histologic Typing of Ovarian Tumors. Vol. 9 [ M ]. Geneva : World Health Organiza- tion, 1973.
  • 4CHO K R,SHIH I E M. Ovarian cancer[J]. Annu Rev Pathol, 2009,4:287-313.
  • 5ROBERT J, KURMAN M D, KALA V, et al. Early detection and treatment of ovarian eaneer: shifting from early stage to minimal volume of disease based on a new model of carcino- genesis [ J ]. Am J Obstet Gyneco1,2008,198 ( 4 ) : 351 - 356.
  • 6CARMEN M G, BIRRER M, SCI-IORGE J O. Clear cell carci- noma of the ovary : a review of the literature [ J ]. Gynecol On- col,2012,126(3 ) :481-490.
  • 7KUO K T,MAO T L,JONES S,et al. Frequent activating muta- tion of PIK3CA in ovarian clear cell carcinoma [ J ]. Am J Patho1,2009,174 ( 5 ) : 1597-1601.
  • 8AZUSA A B E,TAKEO MINAGUCHI. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma[ J]. Hum Patho1,2013,44 : 199-207.
  • 9MUNMUN RAHMAN MBBS, KENTARO NAKAYAMA. Clini- copathologic and biological analysis of PIK3CA mutation in o- varian clear cell carcinoma [ J ]. Hum Pathol, 2012,43 : 2197- 2206.
  • 10JONES S, WANG T L. Frequent mutations of chromatin remod- eling gene ARID1A in ovarian clear cell carcinoma [ J l- Sci- ence, 2010,330 : 228- 231.

共引文献20

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部